Pfizer Oncology - Building a new paradigm in prostate cancer
Expanding the potential of PARP inhibitors
Date
14 Sep 2020Session
Pfizer Oncology - Building a new paradigm in prostate cancerPresenters
Joaquin MateoAuthors
J. MateoAuthor affiliations
- Vall d'Hebron University Hospital, 8035 - Barcelona/ES
Resources
Resources from the same session
Summary
Presenter: Daniel George
Session: Pfizer Oncology - Building a new paradigm in prostate cancer
Resources:
Webcast
Maximizing outcome with NHTs
Presenter: Arnulf Stenzl
Session: Pfizer Oncology - Building a new paradigm in prostate cancer
Resources:
Webcast
Live Q&A - 14 September 2020 - 15:30-16:00
Presenter: Daniel George
Session: Pfizer Oncology - Building a new paradigm in prostate cancer
Resources:
Webcast
Challenges in the treatment of prostate cancer
Presenter: Daniel George
Session: Pfizer Oncology - Building a new paradigm in prostate cancer
Resources:
Webcast
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
-
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.